NJM launches Dara coolvacuum freeze-drying equipment

This freeze dryer fits for R&D labs and commercial fill-finish packaging lines

45
NJM has launched Dara coolvacuum freeze-drying equipment to North America. Photo: NJM
NJM has launched Dara coolvacuum freeze-drying equipment to North America. Photo: NJM

Coolvacuum, freeze-drying equipment by a global manufacturer, Dara Group, has the properties of offering turnkey solutions for freeze-dried injectable drugs. NJM has introduced the product to the United States and Canada. This equipment is believed to become a helping hand for pharmaceutical and biotech manufacturers and contract packers to achieve the highest product quality standards.

Quality is a priority for any pharma and biotech industry. Precision in every aspect and step is a must. To meet the highest quality standards, NJM has launched Dara coolvacuum freeze-drying equipment embedded with a range of lyophilization solutions. This small yet standalone freeze dryer is perfect for R&D labs and large and fully integrated systems for commercial fill-finish packaging lines. The equipment has been designed with Scada software for FDA 21 CFR part 11 compliance to meet FDA, GAMP5, and GMP regulations.

NJM aims to offer aseptic, turnkey, fill-finish lines in freeze dryers

According to Tom Kesler, Dara product manager at NJM, “NJM, in collaboration with Dara, aims towards offering aseptic, turnkey, isolated-based fill-finish lines in their own freeze dryers. Our features include providing best-in-class equipment, seamless integration, and a single contact point for planning, installation, and aftermarket support. Our lyophilization solutions enable the customers to use these lab-scale freeze dryers for R&D and clinical trials and use the same process technology for high-speed manufacturing on a commercial scale.

Along with laboratory freeze dryers, pilot freeze dryers, and commercial freeze dryers, Dara specializes in manufacturing a wide range of equipment for pharma and biotech liquid filling, syringe, and pen device assembling.

Dara Pharma understands that there is a requirement to invest in complex and reliable production lines for the continuous evolution and development of drugs and their routes of administration. This gave the reason for the company to create the complete and most advanced range of multiformat equipment in the market. 

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here